• Home >
  • 2009 United States Oncology Drug Delivery Patterns, Preferences, and Opportunities

2009 United States Oncology Drug Delivery Patterns, Preferences, and Opportunities

Volume 1: Oncologist and Infusion Nurse Perspectives

27-Sep-2012  /  Research Code: NBC1-01-00-00-00  /  SKU: HC02243-NA-CR_07997  /  
Region: North America

Regular Price: USD 10,000.00

Special Price USD 7,500.00

25% OFF

* Required Fields

Regular Price: USD 10,000.00

Special Price USD 7,500.00

PAY BY INVOICE

Be the first to review this product

Drug delivery is an important area of drug development in the pharmaceutical and biotechnology industry. This customer research was completed to understand trends, dynamics, and parameters specific to the delivery of drugs to cancer patients; identify physicians prescribing trends relative to delivery considerations; understand the role of reimbursement in a physician’s choice of drug delivery; and determine product attributes relative to delivery that are considered important by patients and oncologists. This is important for biotechnology products used in this area as companies seek to design new products and evaluate new opportunities for targeted therapies and other cancer treatments.

Table of Contents

2009 United States Oncology Drug Delivery Patterns, Preferences, and Opportunities, U.S. Oncology Drug Delivery: Oncologist and Infusion Nurse PerspectivesU.S. Oncologist and Infusion Nurse PerspectivesU.S. Oncology Drug Delivery: Oncologist and Infusion Nurse Perspectives




Keyword1

Keyword2

Keyword3

Related Research

Top Trends and Outlook in Health IT—HIMSS18 Conference Report

Release Date : 18-Apr-18

Region : North America

Global Life Sciences Industry Outlook, 2018

Release Date : 09-Apr-18

Region : North America

SXSW 2018: SXSW Accelerator and Healthcare

Release Date : 14-Mar-18

Region : North America

Challenges and Opportunities in a Changing Healthcare Environment

Release Date : 14-Mar-18

Region : North America

The Global Immuno-oncology Therapeutics Market—Adoptive T-cell Therapies, Forecast to 2022

Release Date : 19-Jan-18

Region : North America

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.